Recombinant Factor VIIa BI (rFVIIa BI)
021101
Phase 3 mab completed
Quick answer
Recombinant Factor VIIa BI (rFVIIa BI) for Hemophilia A is a Phase 3 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Hemophilia A
- Phase
- Phase 3
- Modality
- mab
- Status
- completed